scispace - formally typeset
A

Asker Ismayilov

Researcher at Project HOPE

Publications -  3
Citations -  466

Asker Ismayilov is an academic researcher from Project HOPE. The author has contributed to research in topics: Tuberculin & Rifapentine. The author has an hindex of 2, co-authored 3 publications receiving 403 citations.

Papers
More filters
Journal ArticleDOI

Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.

Haileyesus Getahun, +71 more
TL;DR: The guidelines strongly recommend systematic testing and treatment of LTBI in people living with HIV, adult and child contacts of pulmonary TB cases, patients initiating anti-tumour necrosis factor treatment, patients receiving dialysis, patients preparing for organ or haematological transplantation and patients with silicosis.
Journal ArticleDOI

Mitigation of Discordant Rifampicin-Susceptibility Results Obtained by Xpert Mycobacterium tuberculosis/Rifampicin and Mycobacterium Growth Indicator Tube

TL;DR: The Xpert MTB/RIF and MGIT testing may be used in sequential sputum samples without increase in the RIF-susceptibility discordance rate, and its clinical relevance may be low.
Proceedings ArticleDOI

Interpretation of indeterminate RIF-susceptibility results obtained by rapid molecular diagnostics test

TL;DR: The indeterminate RIF-susceptibility detected on sputum samples directly by XpertMTB/RIF is significant and this drawback may be resolved with the use of Xpert MTB/ RIF on cultures.